The exposure of DLBCL cell lines to bimiralisib induces important post-translational and transcriptional changes, affecting genes and proteins involved in the PI3K/AKT/mTOR pathway, BCR signaling, NF-kB pathway, mRNA processing, apoptosis, cell cycle, Myc pathway, MAPK/RAS signaling, and glycolysis [8]. Here, PIK3CG is linked to diffuse large B-cell lymphoma.